The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman, Lee Cranmer, W. G. Dixon, K. L. Hyrich, John R. Patterson, D. P.M. Symmons, Mary Toporcer, Michael J. Mastrangelo

Research output: Contribution to journalArticle

2 Scopus citations

Fingerprint Dive into the research topics of 'The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?'. Together they form a unique fingerprint.